NeuroVision vs Standard Neuromonitoring
ConditionNeurologic Deficits
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorRush University Medical Center
About this trial
The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM or conventional hospital based IONM to assess incidence of new-onset neurological injury.
Eligibility criteria
Qualifiers
Patients undergoing a primary single or multilevel lateral spinal surgery procedures for degenerative pathology Diagnosis: myelopathy, radiculopathy, myeloradiculopathy, central stenosis, foraminal stenosis herniated nucleus pulposus, degenerative disc disease, spondylosis, and osteophytic complexes
Patients able to provide informed consent
Disqualifiers
Active infection
Active or history of malignancy
Spinal traumatic injury within the past 2 years
Trial design
Treatments tested in this trial
- NeuroVision® IONM
- Hospital Based IONM
Treatment groups
148 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov